Publications

  1. Lemke A, Brokmeier HM, Leung SB, Mara KC, Mour GK, Wadei HM, Hill JM, Stegall M, Kudva YC, Shah P, Kukla A. Sodium-glucose cotransporter 2 inhibitors for treatment of diabetes mellitus after kidney transplantation. Clin Transplant. 2022 May 20; e14718 [Epub ahead of print]
    View PubMed
  2. Benavides X, Rogers RT, Tan EK, Merzkani MA, Thirunavukkarasu S, Yigitbilek F, Smith BH, Rule AD, Kukla A, Chow GK, Heimbach JK, Taner T, Dean PG, Prieto M, Stegall MD. Complications After Hand-Assisted Laparoscopic Living Donor Nephrectomy. Mayo Clin Proc. 2022 May; 97 (5):894-904 Epub 2022 Apr 25
    View PubMed
  3. Heybeli C, Bentall AJ, Alexander MP, Amer H, Buadi FK, Dispenzieri A, Dingli D, Gertz MA, Issa N, Kapoor P, Kukla A, Kumar S, Lorenz EC, Rajkumar SV, Schinstock CA, Leung N. Kidney Transplant Outcomes of Patients With Multiple Myeloma. Kidney Int Rep. 2022 Apr; 7 (4):752-762 Epub 2022 Jan 10
    View PubMed
  4. Heybeli C, Alexander MP, Bentall AJ, Amer H, Buadi FK, Dean PG, Dingli D, Dispenzieri A, El Ters M, Gertz MA, Issa NS, Kapoor P, Kourelis T, Kukla A, Kumar S, Lacy MQ, Lorenz EC, Muchtar E, Murray DL, Nasr SH, Prieto M, Rajkumar SV, Schinstock CA, Stegall MD, Warsame R, Leung N. Kidney Transplantation in Patients With Monoclonal Gammopathy of Renal Significance (MGRS)-Associated Lesions: A Case Series. Am J Kidney Dis. 2022 Feb; 79 (2):202-216 Epub 2021 June 24
    View PubMed
  5. Merzkani MA, Bentall AJ, Smith BH, Benavides Lopez X, D'Costa MR, Park WD, Kremers WK, Issa N, Rule AD, Chakkera H, Reddy K, Khamash H, Wadei HM, Mai M, Alexander MP, Amer H, Kukla A, El Ters M, Schinstock CA, Gandhi MJ, Heilman R, Stegall MD. Death With Function and Graft Failure After Kidney Transplantation: Risk Factors at Baseline Suggest New Approaches to Management. Transplant Direct. 2022 Feb; 8 (2):e1273 Epub 2022 Jan 13
    View PubMed
  6. Jeet Kaur R, Rizvi SR, Reid C, Johnson BK, Smith BH, McCrady-Spitzer SK, Kremers WK, Dean P, Kukla A, Stegall MD, Kudva YC. P.138: Patients Report Improved Diabetes Distress After Successful Pancreas Transplantation. Transplantation. 2021 Dec 1; 105 (12 Suppl 2):S56
    View PubMed
  7. Jeet Kaur R, Rizvi SR, Reid C, Johnson BK, Smith BH, McCrady-Spitzer SK, Kremers WK, Dean P, Kukla A, Stegall MD, Kudva YC. P.140: Impact of Successful Pancreas Transplantation on Patient Reported Hypoglycemia Outcomes. Transplantation. 2021 Dec 1; 105 (12 Suppl 2):S57
    View PubMed
  8. Rizvi SR, Kaur RJ, Dadlani V, Almodallal Y, Reid CL, Smith BH, Kremers W, Kukla A, Stegall MD, Sadighi Akha AA, Kudva YC. P.155: Altered T Cell Compartment in Type 1 Diabetes With End Stage Renal Disease. Transplantation. 2021 Dec 1; 105 (12 Suppl 2):S63-S64
    View PubMed
  9. Rizvi SR, Kaur RJ, Dadlani V, Almodallal Y, Reid CL, Smith BH, Kremers W, Kukla A, Stegall MD, Akha AAS, Kudva YC. P.157: NK and B Cell Subset Assessment in Type I Diabetes Patients on Waitlist for Pancreas Transplantation. Transplantation. 2021 Dec 1; 105 (12 Suppl 2):S65
    View PubMed
  10. Kukla A, Ventura-Aguiar P, Cooper M, de Koning EJP, Goodman DJ, Johnson PR, Han DJ, Mandelbrot DA, Pavlakis M, Saudek F, Vantyghem MC, Augustine T, Rickels MR. Transplant Options for Patients With Diabetes and Advanced Kidney Disease: A Review. Am J Kidney Dis. 2021 Sep; 78 (3):418-428 Epub 2021 May 14
    View PubMed
  11. Miao J, Pinto E Vairo F, Hogan MC, Erickson SB, El Ters M, Bentall AJ, Kukla A, Greene EL, Hernandez LH, Sethi S, Lazaridis KN, Pichurin PN, Lisi E, Prochnow CA, Zand L, Fervenza FC. Identification of Genetic Causes of Focal Segmental Glomerulosclerosis Increases With Proper Patient Selection. Mayo Clin Proc. 2021 Sep; 96 (9):2342-2353 Epub 2021 June 11
    View PubMed
  12. Hickson LJ, Abedalqader T, Ben-Bernard G, Mondy JM, Bian X, Conley SM, Zhu X, Herrmann SM, Kukla A, Lorenz EC, Kim SR, Thorsteinsdottir B, Lerman LO, Murad MH. A systematic review and meta-analysis of cell-based interventions in experimental diabetic kidney disease. Stem Cells Transl Med. 2021 Sep; 10 (9):1304-1319 Epub 2021 June 09
    View PubMed
  13. D'Costa MR, King RL, Alexander MP, Zhang P, Issa N, Dingli D, Amer H, Singh D, Leung N, Sukov WR, Dean PG, Habermann TM, Kukla A. Epstein Barr Virus-Negative Lymphoplasmacytic Proliferation Limited to the Renal Allograft: A Unique Presentation of a Rare Disease. Kidney Int Rep. 2021 Aug; 6 (8):2223-2227 Epub 2021 May 27
    View PubMed
  14. Murakami N, Mulvaney P, Danesh M, Abudayyeh A, Diab A, Abdel-Wahab N, Abdelrahim M, Khairallah P, Shirazian S, Kukla A, Owoyemi IO, Alhamad T, Husami S, Menon M, Santeusanio A, Blosser CD, Zuniga SC, Soler MJ, Moreso F, Mithani Z, Ortiz-Melo D, Jaimes EA, Gutgarts V, Lum E, Danovitch GM, Cardarelli F, Drews RE, Bassil C, Swank JL, Westphal S, Mannon RB, Shirai K, Kitchlu A, Ong S, Machado SM, Mothi SS, Ott PA, Rahma O, Hodi FS, Sise ME, Gupta S, Leaf DE, Devoe CE, Wanchoo R, Nair VV, Schmults CD, Hanna GJ, Sprangers B, Riella LV, Jhaveri KD, Immune Checkpoint Inhibitors in Solid Organ Transplant Consortium. A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant. Kidney Int. 2021 Jul; 100 (1):196-205 Epub 2020 Dec 24
    View PubMed
  15. Isik B, Alexander MP, Manohar S, Vaughan L, Kottschade L, Markovic S, Lieske J, Kukla A, Leung N, Herrmann SM. Biomarkers, Clinical Features, and Rechallenge for Immune Checkpoint Inhibitor Renal Immune-Related Adverse Events. Kidney Int Rep. 2021 Apr; 6 (4):1022-1031 Epub 2021 Feb 02
    View PubMed
  16. Singh P, Razonable RR, Lorenz EC, DiCaudo DJ, Sukov WR, Bridges AG, Alkhateeb HB, Hogan WJ, Klomjit N, Thirunavukkarasu S, Amer H, Kudva YC, Khamash H, Stegall M, Kukla A. Chronic graft-versus-host disease in pancreas after kidney transplant recipients - An unrecognized entity. Am J Transplant. 2021 Feb; 21 (2):883-888 Epub 2020 Sept 20
    View PubMed
  17. Kukla A, Alexander MP, Turkevi-Nagy S, Merzkani M, Park W, Smith B, Zhang P, Benavides X, D'Costa M, Morales Alvarez C, Denic A, Bentall A, Kudva YC, Stegall M. Mesangial expansion at 5 years predicts death and death-censored graft loss after renal transplantation. Clin Transplant. 2021 Jan; 35 (1):e14147 Epub 2020 Nov 24
    View PubMed
  18. Owoyemi I, Vaughan LE, Costello CM, Thongprayoon C, Markovic SN, Herrmann J, Otley CC, Taner T, Mangold AR, Leung N, Herrmann SM, Kukla A. Clinical outcomes of solid organ transplant recipients with metastatic cancers who are treated with immune checkpoint inhibitors: A single-center analysis. Cancer. 2020 Nov 1; 126 (21):4780-4787 Epub 2020 Aug 12
    View PubMed
  19. Phadke G, Kaushal A, Tolan DR, Hahn K, Jensen T, Bjornstad P, Roncal-Jimenez C, Hernando AA, Lanaspa MA, Alexander MP, Kukla A, Johnson RJ. Osmotic Nephrosis and Acute Kidney Injury Associated With SGLT2 Inhibitor Use: A Case Report. Am J Kidney Dis. 2020 Jul; 76 (1):144-147 Epub 2020 May 05
    View PubMed
  20. Kukla A, Hill J, Merzkani M, Bentall A, Lorenz EC, Park WD, D'Costa M, Kudva YC, Stegall MD, Shah P. The Use of GLP1R Agonists for the Treatment of Type 2 Diabetes in Kidney Transplant Recipients. Transplant Direct. 2020 Feb; 6 (2):e524 Epub 2020 Jan 13
    View PubMed
  21. Issa N, Sanchez OA, Kukla A, Riad SM, Berglund DM, Ibrahim HN, Matas AJ. Weight gain after kidney donation: Association with increased risks of type 2 diabetes and hypertension. Clin Transplant. 2018 Sep; 32 (9):e13360 Epub 2018 Aug 18
    View PubMed
  22. Serrano OK, Kandaswamy R, Gillingham K, Chinnakotla S, Dunn TB, Finger E, Payne W, Ibrahim H, Kukla A, Spong R, Issa N, Pruett TL, Matas A. Rapid Discontinuation of Prednisone in Kidney Transplant Recipients: 15-Year Outcomes from the University of Minnesota. Transplantation. 2017 Apr 03;
    View PubMed
  23. Dean PG, Kukla A, Stegall MD, Kudva YC. Pancreas transplantation. BMJ. 2017 Apr 3; 357:j1321 Epub 2017 Apr 03
    View PubMed
  24. Sheta M, Riad S, Deepak U, Issa N, Birkenbach M, Ibrahim HN, Kukla A. Costimulation pathway blockade in kidney transplant recipients with de-novo rheumatoid arthritis. Clin Nephrol Case Stud. 2017; 5:16-19 Epub 2017 Feb 17
    View PubMed
  25. Tower CM, Reyes M, Nelson K, Leca N, Kieran N, Muczynski K, Jefferson JA, Blosser C, Kukla A, Maurer D, Chandler W, Najafian B. Plasma C4d+ Endothelial Microvesicles Increase in Acute Antibody-mediated Rejection. Transplantation. 2016 Nov 15;
    View PubMed
  26. Krichner, V, Funger, E Finger, E, Bellin, M, Dunn, TB Dunn TB, Gruessner R, Herring B, Humar, A, Kukla A, Matas, AJ, Pruett, TL, Sutherland DE, Kandaswamy R. Long-term Outcomes for Living Pancreas Donors in the Modern Era. Transplantation .
    View PubMed
  27. Ibrahim HN, Foley RN, Reule SA, Spong R, Kukla A, Issa N, Berglund DM, Sieger GK, Matas AJ. Renal Function Profile in White Kidney Donors: The First 4 Decades. J Am Soc Nephrol. 2016 Feb 17;
    View PubMed
  28. Rouphael B, Lankireddy S, Lazaryan A, Kukla A, Ibrahim HN, Matas AJ, Issa N. Outcomes of kidney retransplantation in recipients with prior post-transplant lymphoproliferative disorder. Clin Transplant. 2016 Jan; 30: (1)60-5.
    View PubMed
  29. Issa N, Kukla A, Jackson S, Riad SM, Foster MC, Matas AJ, Eckfeldt JH, Ibrahim HN. Comparison of cystatin C and creatinine-based equations for GFR estimation after living kidney donation. Transplantation. 2014 Oct 27; 98: (8)871-7.
    View PubMed
  30. Kukla A, Radosevich D, Finger E, Kandaswamy K. High urine amylase level and the risk of enteric conversion in solitary pancreas transplant recipients Transplantation Proceedings.2014;46(6):1938-41.
  31. MacDonald D, Kukla AK, Ake S, Berglund D, Jackson S, Issa N, Spong R, Matas AJ, Ibrahim HN. Medical outcomes of adolescent live kidney donors. Pediatr Transplant. 2014 Jun; 18: (4)336-41.
    View PubMed
  32. Berglund D, MacDonald D, Jackson S, Spong R, Issa N, Kukla A, Reule S, Weber M, Matas AJ, Ibrahim HN. Low birthweight and risk of albuminuria in living kidney donors. Clin Transplant. 2014 Mar; 28: (3)361-7.
    View PubMed
  33. Issa N, Ortiz F, Reule SA, Kukla A, Kasiske BL, Mauer M, Jackson S, Matas AJ, Ibrahim HN, Najafian B. The renin-aldosterone axis in kidney transplant recipients and its association with allograft function and structure. Kidney Int. 2014 Feb; 85: (2)404-15.
    View PubMed
  34. Kukla A, Issa N, Jackson S, Spong R, Foster MC, Matas AJ, Mauer MS, Eckfeldt JH, Ibrahim HN. Cystatin C enhances glomerular filtration rate estimating equations in kidney transplant recipients. Am J Nephrol. 2014; 39: (1)59-65.
    View PubMed
  35. Issa N, Kukla A. Peritoneal dialysis immediately after kidney transplantation. Adv Perit Dial. 2014; 30:83-6.
    View PubMed
  36. Faravardeh A, Eickhoff M, Jackson S, Spong R, Kukla A, Issa N, Matas AJ, Ibrahim HN. Predictors of graft failure and death in elderly kidney transplant recipients. Transplantation. 2013 Dec 27; 96: (12)1089-96.
    View PubMed
  37. Issa N, Kukla A, Ibrahim HN. Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidence. Am J Nephrol. 2013; 37: (6)602-12.
    View PubMed
  38. Issa N, Kukla A, Ibrahim HN. The over-exaggerated chronic nephrotoxicity of calcineurin inhibitors. Arab J Urol. 2012 Jun; 10: (2)169-74.
    View PubMed
  39. Kukla A, Issa N, Ibrahim HN. Pregnancy in renal transplantation: Recipient and donor aspects in the Arab world. Arab J Urol. 2012 Jun; 10: (2)175-81.
    View PubMed
  40. Issa N, Lankireddy S, Kukla A. Should peritoneal dialysis be the preferred therapy pre-kidney transplantation? Adv Perit Dial. 2012; 28:89-93.
    View PubMed
  41. Rizzari M, Suszynski T, Gillingham k, Dunn T, Ibrahim HN, Payne W, Chinnakotla S, Finger E, Sutherland D, Kandaswamy R, Najarian J, Pruett T, Kukla A, Spong R, Matas AJ. Ten-year outcome after rapid discontinuation of prednisone in adult primary kidney transplantation Clinical Journal of the American Society of Nephrology.2012;7(3):494-503.
  42. Kukla A, Chen E, Spong R, Weber M, El-Shahawi Y, Gillingham K, Matas AJ, Ibrahim HN. Recurrent glomerulonephritis under rapid discontinuation of steroids Transplantation.2011;91(12):1386-1390.
  43. Kasiske B, Kukla A, Thomas D, Wood Ives J, Snyder J, Qiu T, Peng Y, Dharnidharka V, Israni A. Lymphoproliferative disorders after adult kidney transplant; epidemiology and comparison of registry report with claims-based diagnosis American Journal of Kidney Disease.2011;58(6):971-980.
  44. Ibrahim HN, Kukla A, Cordner G, Bailey R, Gillingham K, Matas AJ. Diabetes after kidney donation American Journal of Transplantation .2010;10(2):331-337.
  45. Kukla A, El-Shahawi Y, Leister E, Kasiske B, Mauer M, Matas M, Ibrahim HN. GFR-estimating models in kidney transplant recipients on a steroid-free regimen Nephrology Dialysis Transplantation.2010;25(5):1653-1661.
  46. Kukla A, Sebasky , M, Akkina S, Leister E, Hongfei G, Matas A, Ibrahim HN. Appraisal of GFR estimating equations following kidney disease American Journal of Kidney Disease.2009;53(6):1050-1058.
  47. Kukla A, Ibrahim HN. Current concepts of chronic kidney disease classification and screening US Nephrology .2009;4(1):19-21.
  48. Kukla A, Adulla M, Pascual J, Samaniego M, Nanovic L, Becker BN, Djamali A. CKD stage-to-stage progression in native and transplant kidney disease Nephrology Dialysis Transplantation .2008;23(2):1050-1058.